K14-TSLPtg PyMttg and PyMttg mice received an i.p. injection of 750 μg anti-CD4 (GK1.5) and/or anti-CD8 (YTS169.4) or control Ab (anti-rat IgG; Sigma-Aldrich) in the second week of life. The animals continued to receive 250 μg depleting Abs weekly. Anti-CD4 and anti-CD8 Abs were produced by the Protein Production and Purification Facility of the Rheumatic Diseases Core Center (RDCC) at Washington University.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.